期刊文献+

氯沙坦对实验性肾衰RAS系统的影响

Effects of Losartan on renin-angiotensin system in the kidney of experimental renal failure
下载PDF
导出
摘要 目的探讨血管紧张素受体拮抗剂氯沙坦(ARB)对血管紧张素受体亚型1(AT1)、血管紧张素受体亚型2(AT2)、血管紧张素转化酶(ACE)、血管紧张素原(AGT)基因表达的影响。方法本试验应用阿霉素(ADR)复制肾衰大鼠模型,采用RT-PCR检测AT1、AT2、ACE、AGT基因表达。结果肾衰组肾脏AT1表达上调,AT2降低,氯沙坦组转为AT1下调,AT2表达接近对照组水平;与对照组相比,肾衰模型AGT水平增高,而给予氯沙坦后其水平降低;ACE在肾衰时表达上调,给氯沙坦后降低但仍高于对照组水平。结论氯沙坦可从调节血管紧张素II(Ang II)生成及受体水平角度对抗AngⅡ的作用,从而避免肾损伤。 Objective To explore the mRNA expression of AT1,AT2,ACE and AGT was determined with RT-PCR method.Methods In this study,after the rat model of renal failure was established by administrating with ADR.Results RT-PCR results showed that adriamycin inducted that upregulation of AGT,ACE and AT1,and down-regulation of AT2,but the down regulation of AGT,AT1 when adriamycin administration.Conclusion ARB can competitively inhibit the acitivity of ANG II through binding with AT1,or down regulate the expression of ANG II receptor,it can protect the kidney from the injury.
出处 《中国实验诊断学》 北大核心 2010年第9期1378-1380,共3页 Chinese Journal of Laboratory Diagnosis
关键词 氯沙坦 肾损伤 RAS系统 Losartan renal failure RAS system
  • 相关文献

参考文献9

二级参考文献71

  • 1[1]Gavras H,Brown JJ,Lever AF,et al.Acute renal failure,tubular necrosis and myocardial infraction induced in the rabbit by intravenous angiotensin Ⅱ[J].Lancet,1971,2:19-22.
  • 2[2]Brunner HR,Laragh JR,Baer L,et al.Essential hepertension:renin and aldosterone,heart attactk and stroke[J].N Engl J Med,1972,286:441-449.
  • 3[3]Messerli FH,Weber MA,Brunner HR.Angiotension Ⅱ receptor inhibitior[J].Arch Intern Med,1996,156:1957-1965.
  • 4[4]Urata H,Strobel F,Ganten D.Widespread tissue distribution of human chymase[J].J Hypertens,1994,12:17-22.
  • 5[5]Weber MA,Byyny RL,Partt JH,et al.Blood pressure effects of the Angiotension Ⅱ receptor blocker,losartan[J].Arch Inter Med,1995,15:405-411.
  • 6[6]Oparil S,Dyke S,Harris F,et al.The efficacy and safey of valsartan compared with placeebo in the treatment of essential hypertension[J].Clin Ther,1996,18:797-810.
  • 7[7]Pool JL,Guthrie RM,Littlejohn TW,et al.Dose-related antihypertensive effects of irbesartan in patients with mide-to-moderate hypertension[J].AM J Hypertens,1998,11:462-470.
  • 8[8]Oparil S,Bar E,Elkins M,et al.Efficacy,tolerability,and effects on quality of life of losartan,alone or with hydrochlorothiazide,in patients with essential hypertension[J].Clin Ther,1996,18:608-625.
  • 9[10]Tikkanen I,Omvik P,Jense HA,et al.Comparison of angiotensin Ⅱ antagonist losartan with the angiotension converting enzyme inhibitor enalapril in patients with essential hypertension[J].J Hypertens,1995,13:1343-1351.
  • 10[11]Weir MR,Elkins M,Liss C,et al.Efficacy,tolerability.and quality of life of losartan,alone or with hydrochlorothiaxide.versus nifediping GITS in patients with essential hypertension[J].Clin Ther,1996,18:411-428.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部